EYLWARD SUSAN (General Counsel and Corp Sec) sold 46.7% of their position (2.54K shares) of IMUNON, INC. on the open market
Open‑market sale worth $4.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/4/2026ACC: 0001437749-26-025661
Officer· General Counsel and Corp Sec
Since Oct 2024
0.00
Net shares
Net seller
$4.0K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
2.54K acquired · 2.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.54K
Price / share
$1.59
Trade value
$4.04K
% of position
87.7%
7/31/2026
2.90K→5.44K
Common Stock
Direct
Shares
−2.54K
Price / share
$1.57
Trade value
$3.98K
% of position
46.7%
8/3/2026
5.44K→2.90K
Total
Net shares
+0.00
Net value
$63.27
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2026 | A · Award | +2.54K | $1.59 | $4.04K | 87.7% | 2.90K | 5.44K |
| Common Stock Direct | 8/3/2026 | S · Sale | −2.54K | $1.57 | $3.98K | 46.7% | 5.44K | 2.90K |
| Total | +0.00 | $63.27 | ||||||
Derivative Transactions0
No derivative transactions reported